Greg D. Aunan - 21 Feb 2026 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Accounting Officer
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
21 Feb 2026
Net transactions value
$0
Form type
4
Filing time
24 Feb 2026, 16:14:19 UTC
Previous filing
05 May 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Aunan Greg D Chief Accounting Officer 9490 NEOGENOMICS WAY, FORT MYERS /s/ Ali Olivo, Attorney-in-Fact 24 Feb 2026 0001646370

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $0 +6,323 +36% $0.000000 23,902 21 Feb 2026 Direct F1
transaction NEO Common Stock Tax liability $0 -1,875 -7.8% $0.000000 22,027 21 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Restricted Stock Unit Options Exercise $0 -6,323 -33% $0.000000 12,648 21 Feb 2026 Common Stock 6,323 $0.000000 Direct F3, F4
holding NEO Stock Option (Right to Buy) 28,662 21 Feb 2026 Common Stock 28,662 $14.62 Direct F5
holding NEO Stock Option (Right to Buy) 26,978 21 Feb 2026 Common Stock 26,978 $13.96 Direct F6
holding NEO Restricted Stock Unit 16,117 21 Feb 2026 Common Stock 16,117 $0.000000 Direct F4, F7
holding NEO Stock Option (Right to Buy) 31,163 21 Feb 2026 Common Stock 31,163 $11.86 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
F2 Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
F3 On February 21, 2025, Mr. Aunan was granted 18,971 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F4 Once vested, the shares of common stock are not subject to expiration.
F5 On May 1, 2023, Mr. Aunan was granted 28,662 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F6 On May 2, 2024, Mr. Aunan was granted 26,978 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F7 On May 2, 2024, Mr. Aunan was granted 16,117 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F8 On February 21, 2025, Mr. Aunan was granted 31,163 stock options. The options vest ratably over the first three anniversary dates of the grant date.